New insights in premature ejaculation

Psychiatric Times

Volumn 24, Issue 9, 2007, Pages 52-55

  Waldinger, Marcel D ^a,b  

^a LEYENBURG HOSPITAL   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34548830430     PISSN: 08932905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Waldinger MD, Schweitzer DH. Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence based definition of premature ejaculation. Part I: Validity of DSM-IV-TR. J Sex Med. 2006;3:682-692.
2. Waldinger MD, Hengeveld MW, Zwinderman AH. Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry. 1994;151:1377-1379.
3. Waldinger MD, Schweitzer DH. Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part II: Proposals for DSM-V and ICD-11. J Sex Med. 2006; 3:693-705.
4. St. Lawrence JS, Madakasira S. Evaluation and treatment of premature ejaculation: a critical review. Int J Psychiatr Med. 1992;22:77-97.
5. Godpodinoff ML. Premature ejaculation: clinical subgroups and etiology. J Sex Marital Ther. 1989;15:130.
6. Waldinger MD. The need for a revival of psychoanalytic investigations into premature ejaculation. J Men's Health Gender. 2006;3:390-396.
7. Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH. Thyroid-stimulating hormone assessments in a Dutch cohort of 620 men with lifelong premature ejaculation without erectile dysfunction. J Sex Med. 2005;2: 865-870.
8. Carani C, Isidori AM, Granata A, et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metabol. 2005; 90:6472-6479.
9. Screponi E, Carosa E, Stasi SM, et al. Prevalence of chronic prostatitis in men with premature ejaculation. Urology. 2001;58:198-202.
10. Jannini EA, Lombardo F, Lenzi A. Correlation between ejaculatory and erectile dysfunction. Int J Androl. 2005; 28:40-45.
11. Althof SE. Psychological treatment strategies for rapid ejaculation: rationale, practical aspects, and outcome. World J Urol. 2005;23:89-92.
12. Assalian P. Guidelines for the pharmacotherapy of premature ejaculation. World J Urol. 2005;23:127-129.
13. Abraham K. Ueber Ejaculatio Praecox [in German]. Zeitschr Aerztl Psychoanal. 1917;4:171-186.
14. Semans JH. Premature ejaculation: a new approach. South Med J. 1956;49:353-358.
15. Masters WH, Johnson VE. Premature ejaculation. Human Sexual Inadequacy. Boston: Little, Brown and Co; 1970:92-115.
16. Waldinger MD. Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology. Int J Impot Res. 2003;15:309-313.
17. Waldinger MD, Zwinderman AH, Schweitzer DH, Olivier B. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res. 2004;16:369-381.
18. Waldinger MD, Olivier B. Utility of selective serotonin reuptake inhibitors in premature ejaculation. Curr Opin Investig Drugs. 2004;5:743-747.
19. Moreland AJ, Makela EH. Selective serotonin-reuptake inhibitors in the treatment of premature ejaculation. Ann Pharmacother. 2005;39:1296-1301.
20. Weinrieb RM, Auriacombe M, Lynch KG, Lewis JD. Selective serotonin re-uptake inhibitors and the risk of bleeding. Expert Opin Drug Saf. 2005;4:337-344.
21. Ahmad S. Paroxetine-induced priapism. Arch Intern Med. 1995;155:645.
22. Fava M, Judge R, Hoog SL, et al. Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment. J Clin Psychiatry. 2000;61:863-867.
23. Black K, Shea C, Dursun S, Kutcher S. Selective serotonin reuptake inhibitor discontinuation syndrome; proposed diagnostic criteria. J Psychiatry Neurosci. 2000; 25:255-261.
24. Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH. Majority of men with lifelong premature ejaculation prefer daily drug treatment: an observational study in a consecutive group of Dutch men. J Sex Medicine. In press.
25. Segraves RT, Saran A, Segraves K, Maguire E. Clomipramine versus placebo in the treatment of premature ejaculation: a pilot study. J Sex Marital Ther. 1993;19:198-200.
26. Berkovitch M, Keresteci AG, Koren G. Efficacy of prilocaine-lidocaine cream in the treatment of premature ejaculation. J Urol. 1995;154:1360-1361.
27. Pryor JL, Althof SE, Steidle C, et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet. 2006;368:929-937.
28. McMahon CG, McMahon CN, Leow U, Winestock CG. Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: a systematic review. BJU Int. 2006;98:259-272.
29. Waldinger MD, Schweitzer DH. Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part II: proposals for DSM-V and ICD-11. J Sex Med. 2006;3: 693-705.
30. Waldinger MD, Zwinderman AH, Schweitzer DH, Olivier B. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res. 2004;16:369-381.